
Amylmetacresol
CAS No. 1300-94-3
Amylmetacresol( Amylmetacresol )
Catalog No. M17931 CAS No. 1300-94-3
Amylmetacresol is used in the treatment of sore throat or ‘acute sore throat’, pharyngitis, tonsillitis and laryngitis. As well as in the treatment of influenza A and SARS-CoV.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
50MG | 26 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameAmylmetacresol
-
NoteResearch use only, not for human use.
-
Brief DescriptionAmylmetacresol is used in the treatment of sore throat or ‘acute sore throat’, pharyngitis, tonsillitis and laryngitis. As well as in the treatment of influenza A and SARS-CoV.
-
DescriptionAmylmetacresol is used as a Topical antiseptic for treatment of sore throat.
-
In Vitro——
-
In Vivo——
-
SynonymsAmylmetacresol
-
PathwayAngiogenesis
-
TargetSyk
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1300-94-3
-
Formula Weight178.27
-
Molecular FormulaC12H18O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (560.95 mM)
-
SMILESCCCCCc1ccc(C)cc1O
-
Chemical Name6-Pentyl-m-cresol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mcnally D, et al, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques, 2012, 15(2):281.
molnova catalog



related products
-
ASN-002
ASN-002 (Gusacitinib, ASN002) is a novel and potent dual inhibitor of SYK/JAK kinases with IC50 of 5-46 nM in biochemical assays.
-
Sovleplenib
Sovleplenib (HMPL523) is an orally available, selective and potent inhibitor of the splenic tyrosine kinase SYK with an IC50 of 25 nM.Sovleplenib has antitumor activity and may be used in studies of immune thrombocytopenia (ITP).
-
R406
R406 is a potent Syk inhibitor with IC50 of 41 nM, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 1.